Ponatinib (AP24534)

Catalog No.S1490

Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.

Price Stock Quantity  
USD 100 In stock
USD 110 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Ponatinib (AP24534) Chemical Structure

Ponatinib (AP24534) Chemical Structure
Molecular Weight: 532.56

Validation & Quality Control

Customer Product Validation(2)

Quality Control & MSDS

Related Compound Libraries

Bcr-Abl Inhibitors with Unique Features

  • Selective Bcr-Abl Inhibitor

    Nilotinib (AMN-107) Bcr-Abl-selective, IC50<30 nM.

  • Most Potent Bcr-Abl Inhibitor

    GZD824 Bcr-Abl(WT), IC50=0.34 nM; Bcr-Abl(T315I), IC50=0.68 nM.

  • FDA-approved Bcr-Abl Inhibitor

    Dasatinib Approved by FDA for CML and Ph+ ALL.

  • Newest Bcr-Abl Inhibitor

    GZD824 Orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Product Information

  • Compare Bcr-Abl Inhibitors
    Compare Bcr-Abl Products
  • Research Area
  • Ponatinib (AP24534) Mechanism

Product Description

Biological Activity

Description Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.
Targets Abl [1]
(Cell-free assay)
PDGFRα [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
FGFR1 [1]
(Cell-free assay)

 View  More

IC50 0.37 nM 1.1 nM 1.5 nM 2.2 nM
In vitro AP24534 potently inhibits native Abl, AblT315I, and other clinically important Abl kinase domain mutants with IC50 of 0.30 nM–2 nM. AP24534 doesn't inhibit Aurora kinase family members, nor does it inhibit insulin receptor or CDK2/cyclin E. AP24534 inhibits proliferation of Ba/F3 cells expressing Bcr-Abl with IC50 of 0.5 nM, as well as Ba/F3 cells expressing a range of Bcr-Abl mutants with IC50 of 0.5 nM–36 nM. The inhibition of proliferation by AP24534 is correlated with induction of apoptosis. [1-2] In leukemic cell lines containing activated forms of FLT3, KIT, FGFR1, and PDGFRα receptors, AP24534 potently inhibits receptor phosphorylation and cellular proliferation with IC50 of 0.3 nM to 20 nM. In MV4-11 (FLT3-ITD(+/+)) but not RS4;11 (FLT3-ITD(–/–)) AML cells, AP24534 inhibits FLT3 signaling and induced apoptosis at less than 10 nM. AP24534 inhibits viability of primary leukemic blasts from a FLT3-ITD positive AML patient with IC50 of 4 nM but not those from patients with AML expressing native FLT3. [3] In Ba/F3 cells engineered to express activated FGFR1-4, AP24534 potently inhibits FGFR-mediated signaling and viability with IC50 lower than 40 nM. In cell lines representing multiple tumor types (endometrial, bladder, gastric, breast, lung, and colon), and containing FGFRs dysregulated by a variety of mechanisms, AP24534 inhibits FGFR-mediated signaling with IC50 less than 40 nM and inhibits cell growth with IC50 of 7 nM–181 nM. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
EoL-1-cellMVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVHrPHhFUUN3ME2wMlAxODByMECzOVkh|ryPMofqV2FPT0WU
MV-4-11M1TicGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkfyTWM2OD1yLkCwNFA6PTZizszNNW\keWVoW0GQR1XS
MEG-01M1;2dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTBwMECwNVI5KM7:TR?=M1zscXNCVkeHUh?=
LAMA-84NVG1XlV{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYPJR|UxRTBwMECwNVY2KM7:TR?=M4DLU3NCVkeHUh?=
CGTH-W-1M{XQSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkDJTWM2OD1yLkCwNVY6KM7:TR?=MW\TRW5ITVJ?
KASUMI-1NEG1OoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYXzUpFFUUN3ME2wMlAxOjF5IN88US=>M{HrSnNCVkeHUh?=
BE-13NV;HXFVwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIDNS25KSzVyPUCuNFAzPTlizszNNGLERodUSU6JRWK=
CTV-1NHXrc49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1frdWlEPTB;MD6wNFUzOSEQvF2=NXLYW5pkW0GQR1XS
NKM-1NI[3N25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{K0cWlEPTB;MD6wNFY2PSEQvF2=NHjTbldUSU6JRWK=
MONO-MAC-6MknaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH[1SYVKSzVyPUCuNFA5OzdizszNNUXRe3BLW0GQR1XS
A204NG\OO5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HjN2lEPTB;MD6wNVIyQCEQvF2=M{DjTXNCVkeHUh?=
GDM-1NYfK[HA5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV;HNmdrUUN3ME2wMlAyQDN|IN88US=>M2qwR3NCVkeHUh?=
AN3-CAM2TwR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jueGlEPTB;MD6wNVg4OyEQvF2=NYDIVmYxW0GQR1XS
BL-70Ml3IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXXXTppuUUN3ME2wMlAzOTl7IN88US=>NFvGWYFUSU6JRWK=
DaudiMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M37WXWlEPTB;MD6wNlU{PyEQvF2=NHrLcHRUSU6JRWK=
KU812MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFzjOIlKSzVyPUCuNFI5PDhizszNNHfJUYdUSU6JRWK=
KG-1MlnrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmezTWM2OD1yLkCzNlk1KM7:TR?=M33KO3NCVkeHUh?=
DOHH-2M1\tSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1\IT2lEPTB;MD6wOFgxOyEQvF2=MUTTRW5ITVJ?
HuO9NYLENWZ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3q5cmlEPTB;MD6wOVQ1QCEQvF2=MVPTRW5ITVJ?
EB2NFuxV3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnG3TWM2OD1yLkC1OVc3KM7:TR?=MXHTRW5ITVJ?
G-402NUS3R4VbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1nsVmlEPTB;MD6wOlM1OSEQvF2=M2\MXnNCVkeHUh?=
SU-DHL-1MnK3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2\5b2lEPTB;MD6wOlM4QSEQvF2=M4\INnNCVkeHUh?=
NCI-H719M3zoZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkCwTWM2OD1yLkC3PFg5KM7:TR?=MWHTRW5ITVJ?
MLMAMkPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTBwMEmwOkDPxE1?NHfrV49USU6JRWK=
KM12NXHXXXF[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWfVVWtUUUN3ME2wMlA6PzN5IN88US=>MV3TRW5ITVJ?
SUP-T1MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3rtT2lEPTB;MD6wPVk5OiEQvF2=MVLTRW5ITVJ?
MZ1-PCNE[yWGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4DwW2lEPTB;MD6xNVM{PiEQvF2=M2OxW3NCVkeHUh?=
MFE-296NYDxNmlpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWLMRVZ[UUN3ME2wMlEyQDN7IN88US=>NV7Ib2lzW0GQR1XS
ALL-POMn\LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmDWTWM2OD1yLkGyOFQ{KM7:TR?=MV3TRW5ITVJ?
GB-1Mon1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1TKUmlEPTB;MD6xNlUyOiEQvF2=NUGy[ZdiW0GQR1XS
SIG-M5NYfIc4piT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIi5NIlKSzVyPUCuNVM{PyEQvF2=MV3TRW5ITVJ?
P30-OHKNHmwXJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkHRTWM2OD1yLkG1OlczKM7:TR?=NF\BcJpUSU6JRWK=
NCI-H716MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1vCbmlEPTB;MD6xOlI3PiEQvF2=Mn:0V2FPT0WU
MPP-89NGHUU2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkfHTWM2OD1yLkG2PVM{KM7:TR?=MmDHV2FPT0WU
SF126NHnWVXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{XiZ2lEPTB;MD6xO|A3OyEQvF2=NYjYdYUzW0GQR1XS
CTB-1NHmyTopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXwTnVKSzVyPUCuNVc{OTZizszNMU\TRW5ITVJ?
CA46NU\HdVNrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTwUWlLUUN3ME2wMlE4PDh7IN88US=>MYTTRW5ITVJ?
NCI-H520MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlS0TWM2OD1yLkG3O|MzKM7:TR?=NHHzfpZUSU6JRWK=
CAL-85-1MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWPRV25DUUN3ME2wMlE4QTJ5IN88US=>M1HVTHNCVkeHUh?=
NCI-H2342NV7Cb|BqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYXIPZJoUUN3ME2wMlE5PTd5IN88US=>MWfTRW5ITVJ?
697MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlG2TWM2OD1yLkG4PFcyKM7:TR?=NVnmdnFJW0GQR1XS
NYNGHu[IZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLLNo1{UUN3ME2wMlE6Ojh5IN88US=>MVPTRW5ITVJ?
T98GMYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH6yXG1KSzVyPUCuNVk{OThizszNNYXaSItyW0GQR1XS
NCI-H1703MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVPKZWxlUUN3ME2wMlE6PjF3IN88US=>M{[2UnNCVkeHUh?=
NCI-H2087NHXVd2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV;JR|UxRTBwMkC0N|kh|ryPNFjabJlUSU6JRWK=
PF-382MnnzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVXaNIp2UUN3ME2wMlIxQDd|IN88US=>MX3TRW5ITVJ?
HCT-116MkDCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXPRWXdbUUN3ME2wMlIyODZ7IN88US=>M1S0ZnNCVkeHUh?=
CAKI-1NI\SNWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTBwMkG2OlYh|ryPMlHnV2FPT0WU
CCF-STTG1MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwMkK0O|Uh|ryPNVG1c2VlW0GQR1XS
D-392MGM{DOXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF;OPHdKSzVyPUCuNlMyPzdizszNMlXlV2FPT0WU
RT-112NUizU4FzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MY\JR|UxRTBwMkO3PVUh|ryPMlW4V2FPT0WU
MES-SAMljKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXXzTI5uUUN3ME2wMlI1OTh5IN88US=>MnHqV2FPT0WU
LC-2-adNYHkdmVUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2TLbGlEPTB;MD6yOFI3PSEQvF2=MVnTRW5ITVJ?
NOS-1MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\MTWM2OD1yLkK0N|Y4KM7:TR?=NY[xN4FxW0GQR1XS
NALM-6MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFP3VHJKSzVyPUCuNlU2PDNizszNNELENVVUSU6JRWK=
TE-15NV3ocZBsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4nXPGlEPTB;MD6yOlA6OSEQvF2=MnzvV2FPT0WU
786-0NWW0cYl7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYewfG53UUN3ME2wMlI3OjJ6IN88US=>MVPTRW5ITVJ?
IST-MES1NFTXSodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MW\JR|UxRTBwMk[4Nlkh|ryPM3[wSHNCVkeHUh?=
KYSE-180MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYDNRlAyUUN3ME2wMlI3QDlzIN88US=>MmC2V2FPT0WU
YTMoPOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVHvOldOUUN3ME2wMlI3QTd2IN88US=>MYnTRW5ITVJ?
A427M{jvU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGXvT4NKSzVyPUCuNlczPjRizszNMVvTRW5ITVJ?
KYSE-450M2PNZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXHLUmxbUUN3ME2wMlI4OzJ7IN88US=>M2fyNnNCVkeHUh?=
HuH-7M{PxVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTBwMke3OlMh|ryPM3THSnNCVkeHUh?=
CAS-1NWf1VZlST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX;JR|UxRTBwMkizNFMh|ryPNETCTmNUSU6JRWK=
KURAMOCHIMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTBwMki0NVkh|ryPMnjPV2FPT0WU
ACHNNUmyVpM4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\Y[VFKSzVyPUCuNlk{OjNizszNMoTVV2FPT0WU
HGC-27NHfZRmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX;DSodCUUN3ME2wMlI6OzV|IN88US=>Mon5V2FPT0WU
A172Mn7wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGDPToNKSzVyPUCuNlk2PzdizszNMljyV2FPT0WU
SNU-449M1m5PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX3JOIZxUUN3ME2wMlI6QTZ2IN88US=>M{LaSXNCVkeHUh?=
SW982NVroflltT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWKwXG1CUUN3ME2wMlI6QTd6IN88US=>NH3ve|lUSU6JRWK=
EFO-21NWPGdpF{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHuPYlKSzVyPUCuN|A1OTFizszNNX;zbohoW0GQR1XS
NCI-H2030NIHzU2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3;GemlEPTB;MD6zNVE3PCEQvF2=NUW5UZBSW0GQR1XS
HT-144MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWXJR|UxRTBwM{GyPEDPxE1?M4fSfnNCVkeHUh?=
MFE-280M1TNXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTBwM{G0OVMh|ryPNIP5WWhUSU6JRWK=
SK-LU-1NFjs[YZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1XndmlEPTB;MD6zNVQ3PiEQvF2=M132OHNCVkeHUh?=
NCI-H2052M1\6[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M17yOWlEPTB;MD6zNVQ5PCEQvF2=NGPKNnFUSU6JRWK=
SK-HEP-1NI[0fVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlr0TWM2OD1yLkOzN|Y5KM7:TR?=M1fDVHNCVkeHUh?=
QIMR-WILNF[5Om1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{POSWlEPTB;MD6zN|QzPCEQvF2=NHrJfGJUSU6JRWK=
A2780MkTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4D2XGlEPTB;MD6zOFMxPCEQvF2=MmfpV2FPT0WU
ACNMYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2TycWlEPTB;MD6zOFg4OyEQvF2=MVjTRW5ITVJ?
BxPC-3MnixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYjJR|UxRTBwM{S5PFkh|ryPM4fjXXNCVkeHUh?=
BCPAPMlHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWrBd2RmUUN3ME2wMlM3ODBzIN88US=>NHHXS5BUSU6JRWK=
HOP-62MkfLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3rKSWlEPTB;MD6zOlExPiEQvF2=M{\UNHNCVkeHUh?=
SW1710MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFXVRlRKSzVyPUCuN|Y1PTVizszNMmnjV2FPT0WU
OPM-2NUOzTm02T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUfOW|R{UUN3ME2wMlM3PDd|IN88US=>NFq1XJhUSU6JRWK=
DBTRG-05MGNFH5dINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;QSG5KSzVyPUCuN|gxPTRizszNM1fHOXNCVkeHUh?=
SK-MEL-24NEfud49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlLITWM2OD1yLkO5O|kyKM7:TR?=MkfXV2FPT0WU
8305CNHr6VHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGfHdm9KSzVyPUCuN|k4QTNizszNNVzGfoNPW0GQR1XS
OVCAR-4NHPy[XlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGqxZ3BKSzVyPUCuOFE2QDZizszNMmXIV2FPT0WU
HLEMkTOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWTm[Xk2UUN3ME2wMlQyQDZizszNM2i0OnNCVkeHUh?=
NCI-H747MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUjJR|UxRTBwNEKxN|ch|ryPMl;pV2FPT0WU
SW780Ml;rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWrYSY92UUN3ME2wMlQzOzR4IN88US=>NUjQTZB1W0GQR1XS
KYSE-150NUS2TWpyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1jUe2lEPTB;MD60NlQyPSEQvF2=NGK2bIZUSU6JRWK=
H4NXLXV4VLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmrUTWM2OD1yLkSyOFUyKM7:TR?=M2XXdnNCVkeHUh?=
SW1088MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH\VOWhKSzVyPUCuOFQ{QSEQvF2=NIHENXFUSU6JRWK=
SF268M37YeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4r2UmlEPTB;MD60OFg3KM7:TR?=M2jnenNCVkeHUh?=
RT4MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTBwNEWxNVEh|ryPNHHBZXRUSU6JRWK=
NCI-H522MlzjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILGdZZKSzVyPUCuOFUzPyEQvF2=MYPTRW5ITVJ?
LCLC-97TM1M2K3b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDuZpFkUUN3ME2wMlQ3OTl3IN88US=>NEDYVmRUSU6JRWK=
CAL-39NHLkNHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkLKTWM2OD1yLkS2OVE6KM7:TR?=MULTRW5ITVJ?
CAL-120M1jTSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\seIxpUUN3ME2wMlQ4PjR|IN88US=>NEjh[lZUSU6JRWK=
ESS-1MnPYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEjOVXZKSzVyPUCuOFc5OjFizszNMnraV2FPT0WU
KARPAS-45MlzDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVvJR|UxRTBwNEi5N|Mh|ryPNVvRc5RkW0GQR1XS
DU-4475NV\FUZNqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTBwNEm1NVEh|ryPNWrHNpN4W0GQR1XS
VMRC-RCZNWO0epdtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlW5TWM2OD1yLkS5PVA1KM7:TR?=MXPTRW5ITVJ?
HOSM3frOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI\QSVBKSzVyPUCuOVA{PjVizszNMWHTRW5ITVJ?
MOLT-16NVHy[ZpvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVzGZYdLUUN3ME2wMlUyQDB6IN88US=>NV7OeWFnW0GQR1XS
RPMI-6666NUW4b5pLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnHtTWM2OD1yLkWyNVM2KM7:TR?=M4HRd3NCVkeHUh?=
K052MnTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4qwfGlEPTB;MD61NlE1KM7:TR?=NHL4fmNUSU6JRWK=
EHEBNVzNe|drT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHraRYFKSzVyPUCuOVIyQDJizszNMkjqV2FPT0WU
MFH-inoNH7tNXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV3qS2tZUUN3ME2wMlUzOzVzIN88US=>MXXTRW5ITVJ?
A4-FukNGmxb2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn\FTWM2OD1yLkWyOVI5KM7:TR?=MVXTRW5ITVJ?
SW1417NH65epNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVXhO4duUUN3ME2wMlUzPzhzIN88US=>MX7TRW5ITVJ?
DoTc2-4510MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWX3clAyUUN3ME2wMlU1QTV6IN88US=>Mk\WV2FPT0WU
TE-12NIjhZXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NU\wVIN7UUN3ME2wMlU2PzN3IN88US=>MYrTRW5ITVJ?
8-MG-BAMnLzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmfpTWM2OD1yLkW2NFU3KM7:TR?=MXXTRW5ITVJ?
ECC12NIP4VmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX\TZWN3UUN3ME2wMlU3PTV6IN88US=>MnX5V2FPT0WU
CHL-1NX;jRoE4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVjxVndrUUN3ME2wMlU4PDZ|IN88US=>MkL5V2FPT0WU
LCLC-103HNV33[WhYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXjITVczUUN3ME2wMlU5OzR2IN88US=>NXHz[mFoW0GQR1XS
OS-RC-2NVXlW5JvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV2wWYk3UUN3ME2wMlU5Ozd7IN88US=>MoGwV2FPT0WU
RO82-W-1NUPXNWFKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2LKNGlEPTB;MD61PVYyPSEQvF2=MVHTRW5ITVJ?
A3-KAWNH3IRpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTBwNkG0Olch|ryPNF75eGNUSU6JRWK=
NCCITMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTBwNkG3NVUh|ryPMXHTRW5ITVJ?
IST-SL2NX7TbI9ET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVHJR|UxRTBwNkK1NlIh|ryPM2TKcnNCVkeHUh?=
GI-ME-NMljMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXq4fWt4UUN3ME2wMlY{ODZ7IN88US=>M3y0UXNCVkeHUh?=
ES6MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmHoTWM2OD1yLk[zNlk2KM7:TR?=MnfHV2FPT0WU
BL-41M1fNTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX;JR|UxRTBwNkOzOVIh|ryPM1noZXNCVkeHUh?=
Ca-SkiNXTSNFZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUjJR|UxRTBwNkS4NUDPxE1?MXrTRW5ITVJ?
HOP-92NUPIe4RwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYPJR|UxRTBwNkW2O|Ih|ryPM4DLbXNCVkeHUh?=
SK-LMS-1NU\Kc5NLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvD[mdKUUN3ME2wMlY3PDdizszNM2r3U3NCVkeHUh?=
EW-13NVjmNGtYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;Vc5dKSzVyPUCuOlY4PzlizszNM4rrfXNCVkeHUh?=
647-VM{PWTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\6TWM2OD1yLk[4NVQ5KM7:TR?=MWTTRW5ITVJ?
JiyoyeP-2003M3nhXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF;EPJhKSzVyPUCuOlk4OzhizszNMl7FV2FPT0WU
WSU-NHLMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mnn5TWM2OD1yLkewPFg4KM7:TR?=NGiwUolUSU6JRWK=
U-698-MM1PtWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTBwN{GwOlMh|ryPM1HMUnNCVkeHUh?=
HC-1NV;CSXA{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTBwN{K0NFUh|ryPMlXTV2FPT0WU
8505CMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLXTWM2OD1yLkeyO|QyKM7:TR?=M3zTdHNCVkeHUh?=
HUTU-80NHzwTnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NY\oPIlJUUN3ME2wMlc{OzR7IN88US=>NWXRR|Y6W0GQR1XS
LB1047-RCCNFTpem9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3L3TWlEPTB;MD63N|U{QCEQvF2=M2Ox[3NCVkeHUh?=
GAMGMnPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlP1TWM2OD1yLkezOlU{KM7:TR?=MmjIV2FPT0WU
CAL-12TNGfIO4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml62TWM2OD1yLkezPFc4KM7:TR?=NHzPR4xUSU6JRWK=
NCI-SNU-1NEHXO5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnKwTWM2OD1yLke3Nlc5KM7:TR?=NFLSNpdUSU6JRWK=
HTC-C3M1nlZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUnJR|UxRTBwN{e0OVEh|ryPM3u0b3NCVkeHUh?=
HPAF-IINFrXT2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTBwN{e1NFEh|ryPNGnBfVFUSU6JRWK=
KGNMmrZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{jjbmlEPTB;MD63PFA5OSEQvF2=MYLTRW5ITVJ?
EFO-27M{jHTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF;HfFJKSzVyPUCuO|g4OzNizszNMWTTRW5ITVJ?
MEL-HONEnyT5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYHqOoRrUUN3ME2wMlc6PDR7IN88US=>MV7TRW5ITVJ?
KYSE-270MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUjtRVNGUUN3ME2wMlgxPTJ7IN88US=>MV7TRW5ITVJ?
NCI-H1755MnTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFLEeHFKSzVyPUCuPFA4OTRizszNNYf6XGo3W0GQR1XS
MFM-223NVPGXWJPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIGwb|JKSzVyPUCuPFE1ODdizszNM2K0RXNCVkeHUh?=
G-361NFfLPZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmHtTWM2OD1yLkixPFk4KM7:TR?=MYrTRW5ITVJ?
ETK-1MknzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH\VfnpKSzVyPUCuPFI1PDFizszNM1LsdnNCVkeHUh?=
LU-99ANYHSNHdET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEfu[I1KSzVyPUCuPFQ4ODFizszNM4TRXnNCVkeHUh?=
IST-MEL1NWnuNHBDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M17re2lEPTB;MD64OVc{OiEQvF2=M1fGeHNCVkeHUh?=
L-540NF7r[|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVzJR|UxRTBwOEW4NFEh|ryPNYLEdG0{W0GQR1XS
U-2-OSNEDrVIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnLOTWM2OD1yLki1PFQ3KM7:TR?=MXzTRW5ITVJ?
HT-1376M1TSUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{XTe2lEPTB;MD64OlA2OSEQvF2=NHnoT2tUSU6JRWK=
COLO-680NM{fuWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmPsTWM2OD1yLki3PVM{KM7:TR?=MnryV2FPT0WU
NCI-H1581NHzFN2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXu3NXNiUUN3ME2wMlg6Ojl5IN88US=>MofkV2FPT0WU
HuCCT1NW[2OppET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MULJR|UxRTBwOEm1OFgh|ryPNInEZ|NUSU6JRWK=
BB30-HNCNF7wbm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHjzcm5KSzVyPUCuPVI1PjlizszNNHvrO5RUSU6JRWK=
NCI-H2347M2TlO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLYTWM2OD1yLkmzNlkzKM7:TR?=NF7FXmhUSU6JRWK=
G-401MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXe0[HNkUUN3ME2wMlk{Pjl3IN88US=>MXzTRW5ITVJ?
NCI-H358NFLTWJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUjKbnZqUUN3ME2wMlk2ODF2IN88US=>MWLTRW5ITVJ?
HCC1395MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTBwOUW0OlEh|ryPMVXTRW5ITVJ?
J82NGDvVlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUTJR|UxRTBwOUW1OFMh|ryPMkTNV2FPT0WU
KE-37NFjEN|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn;2TWM2OD1yLkm2N|g4KM7:TR?=M{L2ZXNCVkeHUh?=
NOMO-1NYKycIR[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHjKelBKSzVyPUCuPVY2PjRizszNMoDVV2FPT0WU
ML-2M3HoR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4HtS2lEPTB;MD65PVc2KM7:TR?=MmntV2FPT0WU
SW872MoPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTBwOUm3O|Uh|ryPNFvvbZJUSU6JRWK=
KYSE-520MlPLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3XvZWlEPTB;MT6wNFQ6PCEQvF2=MXnTRW5ITVJ?
HL-60NX;O[Hg{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2jL[mlEPTB;MT6wNFk4KM7:TR?=MUTTRW5ITVJ?
HDLM-2MonLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFjDWIJKSzVyPUGuNFEzPTJizszNNUC3[XlTW0GQR1XS
MIA-PaCa-2M17Gemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTFwMEGzO|Uh|ryPNE\uWFBUSU6JRWK=
TCCSUPMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYjaepExUUN3ME2xMlAyPzN{IN88US=>NHfq[3NUSU6JRWK=
SH-4M4nyRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmD0TWM2OD1zLkCyNlQ1KM7:TR?=M1rROHNCVkeHUh?=
MG-63NYP3c|JsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnndGpQUUN3ME2xMlAzPjF4IN88US=>NUHzToNnW0GQR1XS
NB6MmfzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3P2fWlEPTB;MT6wN|ExQSEQvF2=NILEdHRUSU6JRWK=
CAL-54NYrVZnZVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\RZ41VUUN3ME2xMlA{QTV7IN88US=>NELJ[|hUSU6JRWK=
DU-145NEjRRY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHHFO|ZKSzVyPUGuNFgxPzNizszNNYLwd4dIW0GQR1XS
HCE-4NWjYdJBuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTFwMEmyPFYh|ryPNIfX[lNUSU6JRWK=
U-266NH[zNoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWTkeVRxUUN3ME2xMlA6PjN|IN88US=>Mn:4V2FPT0WU
HT-1197MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTFwMUG0N|gh|ryPMknXV2FPT0WU
EW-1MkLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVLBVINOUUN3ME2xMlE1OTJ6IN88US=>MorhV2FPT0WU
MHH-NB-11NXLENYZUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVnJR|UxRTFwMUWzOlgh|ryPM2ftVXNCVkeHUh?=
NCI-H2405M4fqcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;XTWM2OD1zLkG2NVYh|ryPNH3ISXlUSU6JRWK=
COLO-668MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn35TWM2OD1zLkG2OFkh|ryPNEnXZpdUSU6JRWK=
IMR-5NELkTHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkX5TWM2OD1zLkG2PVM3KM7:TR?=M3TDTXNCVkeHUh?=
ARH-77NULme24{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fQfGlEPTB;MT6yNlkzPCEQvF2=NWfuenFHW0GQR1XS
BHT-101NGW2[XVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUnucGN[UUN3ME2xMlI{PDlizszNMl7tV2FPT0WU
SCC-25M336XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV2zW5lTUUN3ME2xMlI{PTN4IN88US=>MXTTRW5ITVJ?
NTERA-S-cl-D1MlfvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWXJR|UxRTFwMkSzOFYh|ryPM1zZXHNCVkeHUh?=
MKN28Mom0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEHK[5hKSzVyPUGuNlU3OzZizszNNIDOfldUSU6JRWK=
KS-1NUDmT|J2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MonITWM2OD1zLkK4NlY6KM7:TR?=MYXTRW5ITVJ?
NCI-H1734MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTFwMki5NVMh|ryPM4\ZOHNCVkeHUh?=
ES7MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml;FTWM2OD1zLkK5OVQzKM7:TR?=M4fvdnNCVkeHUh?=
NCI-H838MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTFwM{C2NVUh|ryPNWKxeZJkW0GQR1XS
HEC-1NV7OPHd[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFTmdo5KSzVyPUGuN|M4PTVizszNMm\LV2FPT0WU
ME-180M1zDT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHjOSWtKSzVyPUGuN|c6QTNizszNNYTNW|VTW0GQR1XS
MMAC-SFMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MU\JR|UxRTFwM{m1PVUh|ryPM3\jPHNCVkeHUh?=
IA-LMMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYTScnVVUUN3ME2xMlQxQTF2IN88US=>MljTV2FPT0WU
MN-60M13YPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3HWXWlEPTB;MT60N|EyPCEQvF2=M2X3W3NCVkeHUh?=
SIMANGXqNIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFPN[I9KSzVyPUGuOFg3QDdizszNNHq4UIlUSU6JRWK=
NCI-H1770NX7Vb3dIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmD0TWM2OD1zLkWyNFU1KM7:TR?=NH3LTFRUSU6JRWK=
ONS-76MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUnYblRCUUN3ME2xMlUzOzFzIN88US=>NIHjO|JUSU6JRWK=
LB771-HNCNWmxT3NFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4ixUGlEPTB;MT61N|kxPiEQvF2=MmjYV2FPT0WU
SW48MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGrKZndKSzVyPUGuOVQzPDNizszNNHPhepRUSU6JRWK=
KYSE-140NV:zd41ST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Moj1TWM2OD1zLkW1O|QyKM7:TR?=NVPjVo8{W0GQR1XS
SW626M1fXTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2T6fmlEPTB;MT61PFE3KM7:TR?=NYDZT2l2W0GQR1XS
MC-CARMn[0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTFwNUi2OlMh|ryPM4Xtc3NCVkeHUh?=
D-336MGM3qzSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVHyZopYUUN3ME2xMlYzQTRizszNNFXUTIxUSU6JRWK=
SK-MEL-3NVLtRXZWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVWxPXd{UUN3ME2xMlY{QTB{IN88US=>NHTVXG9USU6JRWK=
MHH-PREB-1NY\0U4xsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlHuTWM2OD1zLk[0OFc{KM7:TR?=M2TBenNCVkeHUh?=
Calu-1M2q5[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGDYU5JKSzVyPUGuOlU{QDZizszNNY\1R3pNW0GQR1XS
HCC1806MmPVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LKVGlEPTB;MT62OlYyOSEQvF2=NEPzVo9USU6JRWK=
A101DNETrfItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2LvcGlEPTB;MT62Olc5OSEQvF2=MnLtV2FPT0WU
A704M{\zeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\O[nlUUUN3ME2xMlY5OzFzIN88US=>NHHWTGxUSU6JRWK=
LB831-BLCM2fidWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWHJR|UxRTFwNkm4OVQh|ryPNI\KfGRUSU6JRWK=
RL95-2MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTFwN{G0OlMh|ryPMV\TRW5ITVJ?
RPMI-2650M{LqOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTFwN{K3NVkh|ryPMoTJV2FPT0WU
NH-12NUXQOJRkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH7vXoZKSzVyPUGuO|M1OjdizszNM3j0b3NCVkeHUh?=
AGSMoezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoL2TWM2OD1zLke2N|U5KM7:TR?=NIjIOoNUSU6JRWK=
NEC8M2PqbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX6wd3lMUUN3ME2xMlc5QTl3IN88US=>MoGyV2FPT0WU
NCI-H2009NXrYZ2lbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3jDSWlEPTB;MT63PVczOSEQvF2=NUTM[IM3W0GQR1XS
A498M{\KXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NE\ycnBKSzVyPUGuPFEzQDJizszNNUL1cHJKW0GQR1XS
NCI-H810NGLtSotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MontTWM2OD1zLkixOlA3KM7:TR?=M3T0cXNCVkeHUh?=
SK-NEP-1NHHKOI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{XJdmlEPTB;MT64N|c3PyEQvF2=M{XseHNCVkeHUh?=
D-542MGNVTVTVZCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX\JR|UxRTFwOEW4OVEh|ryPMnPtV2FPT0WU
KNS-42MofES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnrVTWM2OD1zLki2NlY3KM7:TR?=NHjVOFdUSU6JRWK=
NCI-H2452MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX;GTYFSUUN3ME2xMlg6ODd2IN88US=>Ml[4V2FPT0WU
SK-MEL-2NXm4WYlXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;3XINKSzVyPUGuPVAzPzFizszNMWPTRW5ITVJ?
OVCAR-5M1SxSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX\nO2VXUUN3ME2xMlkxPjd3IN88US=>M3vxbHNCVkeHUh?=
SNG-MNVvSfIIxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXNPGFXUUN3ME2xMlk2QDV6IN88US=>M1P2XHNCVkeHUh?=
A673NYq5cW1JT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlv3TWM2OD1zLkm3OVE3KM7:TR?=M1u5PXNCVkeHUh?=
L-428NXfQPJVsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVHYfmI3UUN3ME2xMlk6OTd7IN88US=>M3LFO3NCVkeHUh?=
KM-H2NIWzVm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXXYSop5UUN3ME2yMlAyODlizszNNYW5Rm1[W0GQR1XS
MC-IXCM2XGcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX3JR|UxRTJwMEKyO|Mh|ryPMkDCV2FPT0WU
COLO-678MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTJwMESyNFch|ryPMoLoV2FPT0WU
MEL-JUSOMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3;RTmlEPTB;Mj6wO|g2OSEQvF2=M4C3W3NCVkeHUh?=
HCC38NWriRoMyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnxPZVHUUN3ME2yMlA5PDN|IN88US=>MofMV2FPT0WU
UACC-62Ml;OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn[1TWM2OD1{LkC4PFU2KM7:TR?=MU\TRW5ITVJ?
OAW-42M4G2PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFjJU5FKSzVyPUKuNFk4OTFizszNM1TZZnNCVkeHUh?=
LB996-RCCMoDMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGjIUWRKSzVyPUKuNVM5OTdizszNNHnqbZBUSU6JRWK=
COR-L105Mm\rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVTJR|UxRTJwMU[zO|Mh|ryPNFLIXppUSU6JRWK=
RCC10RGBNWTE[oR[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33XS2lEPTB;Mj6xPFU4PiEQvF2=NWfSU2dIW0GQR1XS
A431MoPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2r6PGlEPTB;Mj6xPVAyQSEQvF2=NHG1RmZUSU6JRWK=
NCI-H292MkDhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17SXWlEPTB;Mj6yN|k2OSEQvF2=MUjTRW5ITVJ?
SK-UT-1NH3mN5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlHtTWM2OD1{LkOzNVg1KM7:TR?=M1G2cXNCVkeHUh?=
PANC-08-13MorKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVrJR|UxRTJwM{OyN|Uh|ryPNFLXdZZUSU6JRWK=
ST486MkXiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M131fWlEPTB;Mj60NVA1QCEQvF2=M{\sZXNCVkeHUh?=
SJSA-1MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHvvO4ZKSzVyPUKuOFEzPzFizszNM1y3OHNCVkeHUh?=
RKOMnO1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1j2WGlEPTB;Mj60NlAzQSEQvF2=MXHTRW5ITVJ?
NCI-H1793M2TkTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUXuWVhyUUN3ME2yMlQ1ODJ7IN88US=>NHXVOGdUSU6JRWK=
639-VM{DiSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTJwNEWzPFIh|ryPM1L0d3NCVkeHUh?=
ES3NIjZWmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDJcXlKSzVyPUKuOFk4OzdizszNM3XVd3NCVkeHUh?=
NCI-H1792M3;p[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPlRYI5UUN3ME2yMlU3QDJ4IN88US=>MXHTRW5ITVJ?
NCI-H1651MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2DEcWlEPTB;Mj61PFIyKM7:TR?=NVvycJhbW0GQR1XS
SN12CNYHvPXNnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWfPc|F3UUN3ME2yMlU5PDh5IN88US=>NXzhZWEzW0GQR1XS
COLO-679NX61UG45T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTNTWM2OD1{LkW4OlA2KM7:TR?=Ml7VV2FPT0WU
U-118-MGM1HYb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmDWTWM2OD1{LkW4PFczKM7:TR?=M17GfnNCVkeHUh?=
Ramos-2G6-4C10MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWPUcoNMUUN3ME2yMlY1QDB5IN88US=>NVvkSmlOW0GQR1XS
HCT-15NVf3PWRMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTJwNki3PVIh|ryPNX:4VFB3W0GQR1XS
MDA-MB-157M2fibmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW[wcXZMUUN3ME2yMlcxPzR5IN88US=>M3n1PXNCVkeHUh?=
K5NGXZN3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWrZNYJuUUN3ME2yMlcyQDR3IN88US=>MX3TRW5ITVJ?
MKN45NESw[GdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDRTVJKSzVyPUKuO|M{PjZizszNM2L3Z3NCVkeHUh?=
DMS-273NWG5RY54T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mmj0TWM2OD1{Lke1OlMzKM7:TR?=MmPlV2FPT0WU
C8166MkXwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4PXXWlEPTB;Mj63PFUyOyEQvF2=MX\TRW5ITVJ?
Calu-3MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzxSmtNUUN3ME2yMlc5QTZ7IN88US=>MkPiV2FPT0WU
SNB75MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1LjPWlEPTB;Mj64PFU{PSEQvF2=MonpV2FPT0WU
BFTC-905MlPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnvETWM2OD1{LkmwNVkyKM7:TR?=NED0ZpRUSU6JRWK=
C-4-IINXHwXVNGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MY\JR|UxRTJwOUGzOVMh|ryPNF3KWJhUSU6JRWK=
MS-1NInwOnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWW4dnBJUUN3ME2yMlk3PzZ7IN88US=>NY\KXGI2W0GQR1XS
A375MmX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XrU2lEPTB;Mz6wPFE5PCEQvF2=MUDTRW5ITVJ?
KYSE-70NInhOGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXPJR|UxRTNwMEi4PFIh|ryPNVnXcWZXW0GQR1XS
KYSE-510MnLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoKxTWM2OD1|LkGwPVk2KM7:TR?=M173SHNCVkeHUh?=
LN-405M2LvW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnvOTWM2OD1|LkGzOVE5KM7:TR?=MVfTRW5ITVJ?
BOKUMn3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGDG[VNKSzVyPUOuNVQzPTZizszNMXjTRW5ITVJ?
TE-10Mn7KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTNwMUezOlIh|ryPMV7TRW5ITVJ?
MKN1M3HO[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUfEXWd[UUN3ME2zMlE5PDh|IN88US=>MYjTRW5ITVJ?
M059JM{\Hcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWHrfmlNUUN3ME2zMlIxOTd|IN88US=>NV3mTIxtW0GQR1XS
GOTONGLBTYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjMb5FwUUN3ME2zMlIzODN7IN88US=>NXXlO3MyW0GQR1XS
DK-MGNHz2cGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWDJR|UxRTNwMkW5O|Yh|ryPM4C3d3NCVkeHUh?=
NCI-H727MnuxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2jxRmlEPTB;Mz6yOlU5KM7:TR?=NXHNVpUyW0GQR1XS
NB12MkDRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{LnRWlEPTB;Mz6zN|IzPCEQvF2=MWrTRW5ITVJ?
DOKNILtUJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mnq0TWM2OD1|LkO2NVg3KM7:TR?=M{HpNHNCVkeHUh?=
KYSE-410NVrKb5RHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFOzTGhKSzVyPUOuN|YzQDdizszNMkO5V2FPT0WU
AM-38NVHFTWR2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvjbY5lUUN3ME2zMlM5ODVzIN88US=>MlHjV2FPT0WU
GR-STNXjXU4h4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRTNwNEW3N|Ih|ryPNEW3cZRUSU6JRWK=
D-247MGM3S1U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVvnbGY5UUN3ME2zMlQ5OjZ|IN88US=>M3rHPXNCVkeHUh?=
TE-8M33Rd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXLNXNKSzVyPUOuOFk{OzNizszNNHXPSVNUSU6JRWK=
LS-411NMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPOTWM2OD1|LkS5OlkzKM7:TR?=NXPiXWxJW0GQR1XS
SK-MES-1NIDSU|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV7JR|UxRTNwNU[0N|Mh|ryPMlHLV2FPT0WU
SF295MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGfZW4hKSzVyPUOuOlE2PTJizszNMoLSV2FPT0WU
SK-MEL-30NXLvOpF2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTNwNkW5NlEh|ryPNUTO[5ZqW0GQR1XS
LB2241-RCCNGG4Z29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYHxV4ZjUUN3ME2zMlY3OjZizszNMlr3V2FPT0WU
PC-14NXrLcVhIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmK3TWM2OD1|Lk[2OFM4KM7:TR?=NXK0bHVKW0GQR1XS
EW-7MnX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWLmUWlNUUN3ME2zMlY4Pjl|IN88US=>NYjsdJdwW0GQR1XS
NMC-G1MnjYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUHjUlgxUUN3ME2zMlcyQDN5IN88US=>M{jwb3NCVkeHUh?=
TE-441-TM16xXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTNwN{OwNlgh|ryPNYXHenNNW0GQR1XS
NCI-H1618NGHP[5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjwboVxUUN3ME2zMlgyQDd3IN88US=>Mk\JV2FPT0WU
PANC-03-27NHjGO21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEWwPJRKSzVyPUOuPFE6OTZizszNMkKyV2FPT0WU
NCI-H2228MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoDyTWM2OD1|LkizNVI3KM7:TR?=NFmxbHdUSU6JRWK=
CAPAN-1MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3PETWlEPTB;Mz64O|AxQSEQvF2=MWrTRW5ITVJ?
KLEM1zQTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1S0bWlEPTB;Mz65NFY4KM7:TR?=MlvBV2FPT0WU
BeckerNVfQUIRtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTNwOUK4OFkh|ryPNVzGZlVjW0GQR1XS
SK-PN-DWM2e0VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTRwMEe5O|Qh|ryPM2\qPHNCVkeHUh?=
Hs-578-TM2rTbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYDJR|UxRTRwMEizNFYh|ryPMUfTRW5ITVJ?
RS4-11MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPwTWM2OD12LkGxNlU2KM7:TR?=NVi0bmdpW0GQR1XS
D-502MGMn7jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVvS[YFCUUN3ME20MlE3QTl5IN88US=>NFn1XVlUSU6JRWK=
GI-1MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHDTWM2OD12LkK4Nlk6KM7:TR?=M4O0RXNCVkeHUh?=
NCI-H209NXe1b|VET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3rTS2lEPTB;ND6zN|c5KM7:TR?=M3TFT3NCVkeHUh?=
SK-OV-3NF3heFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV\uOZFqUUN3ME20MlQ5OTR7IN88US=>M4rwU3NCVkeHUh?=
LOUCYMmf1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH[4VINKSzVyPUSuOFg1OzJizszNMl7CV2FPT0WU
NCI-H69NVLqd2FrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1nlVGlEPTB;ND61NVc6OyEQvF2=MWrTRW5ITVJ?
SCC-9MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkP0TWM2OD12LkWzNVczKM7:TR?=NGS5XYhUSU6JRWK=
NCI-H526NVTj[mJCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUnJR|UxRTRwNUmyPVMh|ryPMW\TRW5ITVJ?
NCI-H2170MkmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2PIXmlEPTB;ND62Olc4OSEQvF2=MmrTV2FPT0WU
SRMoLjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHfDNmhKSzVyPUSuO|AxPDhizszNNEjxOoRUSU6JRWK=
CMKNFnGTVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTRwN{KxNFEh|ryPNU[5WW1wW0GQR1XS
COLO-829MknSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NG\qd45KSzVyPUSuO|cxPDNizszNNWHrdI9UW0GQR1XS
HuO-3N1MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXvSfZBqUUN3ME20Mlg{OjhzIN88US=>MXLTRW5ITVJ?
5637NXLZ[VJjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTRwOUC0PFch|ryPMl\nV2FPT0WU
A253NEjVeohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUXhUnZZUUN3ME20Mlk4PzB6IN88US=>MoriV2FPT0WU
NB10NYD4Vm9jT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFK4bYtKSzVyPUWuNFc1QTdizszNMm\TV2FPT0WU
SF539NFvkN|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYmzXGQ4UUN3ME21MlA6QTV7IN88US=>NYDjTXFsW0GQR1XS
HAL-01MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWLyWId[UUN3ME21MlE1PjR3IN88US=>MXjTRW5ITVJ?
MHH-ES-1Mnv5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{DqV2lEPTB;NT6xOlkzPSEQvF2=MYLTRW5ITVJ?
DELM3zSXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV3JR|UxRTVwMke1PFIh|ryPMn3sV2FPT0WU
NCI-H1299MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYLnW2lvUUN3ME21MlM2ODB5IN88US=>NIftTXdUSU6JRWK=
ChaGo-K-1MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlqwTWM2OD13LkO1NVA4KM7:TR?=M{fxUXNCVkeHUh?=
HMV-IINYDyd4FQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnj5TWM2OD13LkO5OFMh|ryPNGjhNJFUSU6JRWK=
NB69NVvmVnd6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWTtdItVUUN3ME21MlM6PjNzIN88US=>MXnTRW5ITVJ?
NCI-H1882NFrVTW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rRbGlEPTB;NT60N|M3PCEQvF2=NXvUVJdOW0GQR1XS
SNU-475M3nMSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4\zNGlEPTB;NT60O|E4OSEQvF2=M1zLcXNCVkeHUh?=
RXF393Mn;qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYfYWnZ6UUN3ME21MlQ5PDl2IN88US=>M2DyNHNCVkeHUh?=
CAL-51NVezcVI6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIn3PWxKSzVyPUWuOlI5PTNizszNMWXTRW5ITVJ?
SW1573NYrLdGNTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn:zTWM2OD13Lk[zOVM1KM7:TR?=NHPhb3VUSU6JRWK=
GCTNWLZS4l5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYLJR|UxRTVwN{W5Nlkh|ryPMV7TRW5ITVJ?
COR-L88NUnxWo5[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYDhR2dwUUN3ME21Mlc3QDR4IN88US=>MWrTRW5ITVJ?
MDA-MB-134-VINIjJUGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWK4T29OUUN3ME21Mlg4PTN4IN88US=>MnrKV2FPT0WU
NB5NYjUeVJsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\NTWM2OD13LkmyOFQh|ryPNWjHSVZXW0GQR1XS
GMS-10Mof2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1zFZ2lEPTB;NT65Olg3OSEQvF2=NH:yUYdUSU6JRWK=
CHP-212MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGDTfGZKSzVyPU[uOFgzPjdizszNNVTjR5ZWW0GQR1XS
TE-11MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mmm5TWM2OD14LkW1NVgzKM7:TR?=MWHTRW5ITVJ?
SW962Ml\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUXJR|UxRTZwNkW3O|Qh|ryPM2nkOnNCVkeHUh?=
MZ2-MELNHzpephIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWPJR|UxRTZwOEKwNVEh|ryPMkL5V2FPT0WU
C-33-ANFqwbmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV3qV4poUUN3ME22MlkyPjh6IN88US=>MVrTRW5ITVJ?
IGR-1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYH0Xmk5UUN3ME22Mlk4QDJ4IN88US=>MlHmV2FPT0WU
MOLT-4NEXHOnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3qxbmlEPTB;Nz6xOVQxPiEQvF2=NE[3WWRUSU6JRWK=
NCI-H1650NE\0eZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mo\FTWM2OD15LkK3NFQ3KM7:TR?=M4TyXHNCVkeHUh?=
AsPC-1MoHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mm\nTWM2OD15LkK4OlA2KM7:TR?=NE\OflRUSU6JRWK=
SNU-C2BNYDBRoU3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\4TWM2OD15LkK5OVcyKM7:TR?=MnP4V2FPT0WU
MKN7MlP0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTdwM{eyN|Uh|ryPNUG3VJBtW0GQR1XS
SW620MoXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF6xU4NKSzVyPUeuN|gzODVizszNMnTOV2FPT0WU
SK-MEL-28M3jjPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3jQZmlEPTB;Nz60NFc6QCEQvF2=MnjwV2FPT0WU
TE-6Mn\mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLRTWM2OD15LkS0PVA5KM7:TR?=M4T4dnNCVkeHUh?=
D-263MGMmDzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\HU2lEPTB;Nz60OVc3OiEQvF2=M3y5NHNCVkeHUh?=
NCI-H1355MknJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4PJWWlEPTB;Nz63O|AzQSEQvF2=NFXJbWVUSU6JRWK=
DSH1M3ftOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlvZTWM2OD15Lke5O|YzKM7:TR?=NGD5XWVUSU6JRWK=
NCI-H460Mki5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILtNZdKSzVyPUiuNFA3QTRizszNNUfiZm9{W0GQR1XS
NCI-H1563MmnmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{P0NGlEPTB;OD6wO|UxQCEQvF2=M3TE[nNCVkeHUh?=
SW948Mn6xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NY\LZ295UUN3ME24MlExPzR2IN88US=>MVvTRW5ITVJ?
LK-2NF:3S29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXLN5VKSzVyPUiuNVI5OzNizszNMVnTRW5ITVJ?
HT-1080NIXE[2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\ncmtKSzVyPUiuNVMyPzVizszNNX\LboI4W0GQR1XS
NCI-H441MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGnzOGhKSzVyPUiuNVk{KM7:TR?=MnXqV2FPT0WU
HSC-4M4T1SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGL3VZZKSzVyPUiuNlg4OiEQvF2=NHzwZmRUSU6JRWK=
LXF-289NXnsXo84T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWHJR|UxRThwM{W5OFMh|ryPM4fic3NCVkeHUh?=
MRK-nu-1NVvSPIduT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTVTndZUUN3ME24MlM3OzB2IN88US=>M{HhUHNCVkeHUh?=
no-11NWrVbYRZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2X4[WlEPTB;OD60O|E{OyEQvF2=MUHTRW5ITVJ?
SNU-387NEHnbYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUnJR|UxRThwNkOyOFYh|ryPMYrTRW5ITVJ?
Detroit562MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVLMTZlDUUN3ME24Mlc2PDV3IN88US=>M2q5[XNCVkeHUh?=
SW954NULLXWttT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PMUGlEPTB;OD63Olg{OiEQvF2=MXLTRW5ITVJ?
P12-ICHIKAWAMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;0TWM2OD16Lke4PVQh|ryPM4T2OnNCVkeHUh?=
TE-9NUfQTHlRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHj5S45KSzVyPUiuPFExPjJizszNMlvhV2FPT0WU
NB13NX;pUY1LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{O0OWlEPTB;OD64N|c6PiEQvF2=M1XtXHNCVkeHUh?=
BPH-1NYPjXJNCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRThwOEWwPFEh|ryPMUPTRW5ITVJ?
KMOE-2M2K2WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NInEflFKSzVyPUiuPFc5QTJizszNM4Ll[nNCVkeHUh?=
RPMI-8402NEj1OnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4nyWGlEPTB;OD64PVkzPiEQvF2=NHPhWYRUSU6JRWK=
OVCAR-3NWLBUmw6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYTJR|UxRThwOUe3N|Ih|ryPNWjZSGpRW0GQR1XS
NCI-H2196NXuzXHN3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmTSTWM2OD16Lkm4OlA3KM7:TR?=NXzzXFJxW0GQR1XS
MZ7-melM{\5PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWDCNlNUUUN3ME25MlA{PDZizszNM{i1UXNCVkeHUh?=
GP5dM4\POmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4Lzb2lEPTB;OT6wOlMyOyEQvF2=NX\pPVNoW0GQR1XS
NCI-N87MnLOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWP4SFNNUUN3ME25MlQ1PzNzIN88US=>MmfHV2FPT0WU
EW-16NY\sR2hTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV7BRohjUUN3ME25MlQ1QDR6IN88US=>NXHl[Yo4W0GQR1XS
Calu-6MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIjmcY5KSzVyPUmuOFk4ODNizszNNYXFcXRMW0GQR1XS
LC4-1Mn;pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIrheo1KSzVyPUmuOlI2PyEQvF2=M4rxNHNCVkeHUh?=
CCRF-CEMNV[1N2s5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mon4TWM2OD17Lk[4O|Y3KM7:TR?=NH\L[|NUSU6JRWK=
BC-1NYf6U5ZXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1\mS2lEPTB;OT63PFk6KM7:TR?=NE\K[YxUSU6JRWK=
NCI-SNU-16MonUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEW1TY1KSzVyPUmuO|k1QTVizszNM1;hZ3NCVkeHUh?=
NCI-H28NELTbZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWfJR|UxRTlwOES5N|Mh|ryPMWfTRW5ITVJ?
SBC-1NILtWlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTFyLkC3NkDPxE1?NUTTNI9nW0GQR1XS
TURMkHaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M16xZ2lEPTB;MUCuNVY2PyEQvF2=NIntUFlUSU6JRWK=
MDA-MB-231NVP3dmxZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHG0XG5KSzVyPUGwMlIyOTRizszNMn20V2FPT0WU
C3AMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHRTWM2OD1zMD6zNVc6KM7:TR?=MVfTRW5ITVJ?
SW1990NXv3THhGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHnUVI1KSzVyPUGwMlMzQCEQvF2=Mm\3V2FPT0WU
NCI-H1993M{izUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV7JR|UxRTFyLkW2PVMh|ryPMoHaV2FPT0WU
SK-CO-1NVjsfHFWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml;GTWM2OD1zMD63O|ch|ryPMUjTRW5ITVJ?
OAW-28M2\LV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NG\ZTWtKSzVyPUGwMlk5QDhizszNMoriV2FPT0WU
HNM2jwZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXZe2RKSzVyPUGxMlEyOzFizszNMlP4V2FPT0WU
NCI-H1304M1XlXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4\sZ2lEPTB;MUGuNVU4PiEQvF2=NGHlPJZUSU6JRWK=
DaoyNEPsNHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIe0RYJKSzVyPUGxMlQ{OzZizszNNH;NNoFUSU6JRWK=
VA-ES-BJNHPMRVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXIfGZKSzVyPUGxMlcyQTVizszNM2TUOHNCVkeHUh?=
MCF7M1LiSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmPPTWM2OD1zMT64NVI3KM7:TR?=NEHNXVZUSU6JRWK=
VM-CUB-1NVfWVYJxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\nSVZmUUN3ME2xNU46ODlzIN88US=>MXfTRW5ITVJ?
IPC-298MmfyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTFzLkmzPFMh|ryPNVHTTpFvW0GQR1XS
NCI-H2126Mn;QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVPJR|UxRTF{LkCyNVgh|ryPNFrC[YZUSU6JRWK=
OVCAR-8NXriU|Z1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDTPHV2UUN3ME2xNk4yOTRzIN88US=>MojOV2FPT0WU
SJRH30NGW2WHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIT0NotKSzVyPUGyMlIzQTlizszNMmHqV2FPT0WU
DMS-53NE\zSJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEL2epJKSzVyPUGyMlI3PDlizszNM3P5S3NCVkeHUh?=
NCI-H322MM4S3VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTF{LkOzOVch|ryPMlHwV2FPT0WU
RVH-421NHjaTWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3foO2lEPTB;MUKuOFkxPCEQvF2=Mlf2V2FPT0WU
RajiNWfFR|N4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTF{Lk[xOEDPxE1?MnTNV2FPT0WU
MDA-MB-415M{DvOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3fu[WlEPTB;MUKuOlQ1PCEQvF2=M1uzRXNCVkeHUh?=
EFE-184M{f0XGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nWWGlEPTB;MUKuO|ExPiEQvF2=Mn7aV2FPT0WU
BFTC-909MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWPJR|UxRTF{LkmyOFch|ryPMXjTRW5ITVJ?
BHYNH3t[WdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{C5d2lEPTB;MUOuN|M6KM7:TR?=NUiwXG9TW0GQR1XS
YKG-1M4LqTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHfTPJBKSzVyPUGzMlM4PDlizszNMlTjV2FPT0WU
EW-3MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml7lTWM2OD1zMz63NVY{KM7:TR?=Mn\MV2FPT0WU
HCC1143Mn;BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NELldppKSzVyPUGzMlc1OzdizszNMoDHV2FPT0WU
REHM2HIWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTF|Lki5PFIh|ryPNGLmTFRUSU6JRWK=
CESSNHnXTJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXjUZZo{UUN3ME2xN{46PDh7IN88US=>M3LTSHNCVkeHUh?=
EFM-19M3[yV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkjvTWM2OD1zND6xNVEzKM7:TR?=NH22Z2lUSU6JRWK=
U031M{\WS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXJR|UxRTF2LkSwPFUh|ryPMWfTRW5ITVJ?
ES1M{XMbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1nMSmlEPTB;MUSuOFg2OSEQvF2=NVn5NmJSW0GQR1XS
HSC-3NFjj[WdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIO0[pRKSzVyPUG0MlYzOTVizszNM2\sXnNCVkeHUh?=
LOXIMVIMlSxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWDpUnBsUUN3ME2xOE44ODZ6IN88US=>MUTTRW5ITVJ?
A388NIrZO4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYTRTXlXUUN3ME2xOE44PTV4IN88US=>MmXOV2FPT0WU
KP-N-YSMnTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTF2Lke3N{DPxE1?M3XxTnNCVkeHUh?=
Capan-2MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTF2Lke4OkDPxE1?MojEV2FPT0WU
SKG-IIIaNYr5[ohUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MU\JR|UxRTF2Lki4OlIh|ryPNXnjbnhVW0GQR1XS
HELMnXLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUTJR|UxRTF2Lki5PVch|ryPNYLIPXVSW0GQR1XS
BENNVrUOnNbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{\uSmlEPTB;MUSuPVc3PiEQvF2=MlKwV2FPT0WU
MC116MofKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rsOGlEPTB;MUWuNVU6QSEQvF2=NFLmcm1USU6JRWK=
IGROV-1NIXOVY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnXMTWM2OD1zNT6yN|E4KM7:TR?=MmfCV2FPT0WU
NCI-H1648MkDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEDGWZFKSzVyPUG1MlU{ODVizszNNFvYT3hUSU6JRWK=
ABC-1NHHLPHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYTl[IF3UUN3ME2xOU45ODN|IN88US=>NXTuWYpZW0GQR1XS
EW-18MonDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYfmRXpNUUN3ME2xOU46QTd7IN88US=>NIe0eGxUSU6JRWK=
BC-3M{fseWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTF4LkC1OlIh|ryPM37oeHNCVkeHUh?=
NCI-H1437M33jZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXjwOXhbUUN3ME2xOk4xPjZ5IN88US=>MorzV2FPT0WU
SCC-15MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4PYXGlEPTB;MU[uNlgzPSEQvF2=NFOzeYxUSU6JRWK=
TTNGPT[HpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{PBXWlEPTB;MU[uOVg5QCEQvF2=MUnTRW5ITVJ?
KINGS-1M1[1fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjYXmlKSzVyPUG2MlgzPzNizszNMWrTRW5ITVJ?
C32MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEjwZYhKSzVyPUG2Mlk4OTdizszNM4jpXHNCVkeHUh?=
SBC-5Mm\MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{XQ[GlEPTB;MUeuNVQ4QSEQvF2=MUPTRW5ITVJ?
NB1M3Xm[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{ThOGlEPTB;MUeuN|E5QCEQvF2=MWLTRW5ITVJ?
EB-3NVrhe5RrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVLVV4syUUN3ME2xO{42PzZizszNNE\Te5NUSU6JRWK=
NCI-H748M3j4bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXOT4dKSzVyPUG3MlcxOzVizszNM1Twc3NCVkeHUh?=
IST-SL1NXjUOo1XT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVLJR|UxRTF5Lke1NlYh|ryPNHjwT4NUSU6JRWK=
WM-115M2rYS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NETq[ItKSzVyPUG3MlgxQDVizszNMVnTRW5ITVJ?
NCI-H226M3PwXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NE\qbFJKSzVyPUG3Mlk2PDZizszNNIi3[lVUSU6JRWK=
CAL-33NVS5dW9VT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFv6c3dKSzVyPUG4MlI4QDFizszNMn\SV2FPT0WU
SCC-4M{XrcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWfJR|UxRTF6LkOyNlkh|ryPNFjl[WpUSU6JRWK=
RMG-IM2[wbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXXTWM2OD1zOD62PVQ4KM7:TR?=M{DLU3NCVkeHUh?=
KOSC-2M1jp[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTF6Lke3OFYh|ryPM3G0U3NCVkeHUh?=
A2058M2LERWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYK2WZprUUN3ME2xPE45OjV3IN88US=>MXTTRW5ITVJ?
HCC70MmPtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPpTWM2OD1zOT6zPFk1KM7:TR?=MojPV2FPT0WU
C2BBe1M4m1cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXHrO3NLUUN3ME2xPU41OTR6IN88US=>MV;TRW5ITVJ?
NCI-H650NH34XmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH70PXRKSzVyPUG5MlU5QTlizszNNGLEToNUSU6JRWK=
CAL-72M1vJPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUPJR|UxRTF7Lk[3N|ch|ryPMYDTRW5ITVJ?
L-363NH3DRmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYDJR|UxRTJyLkCyNVIh|ryPNUjodZc5W0GQR1XS
SNU-423M1HVb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHnxZpBKSzVyPUKwMlExPDNizszNM1\p[3NCVkeHUh?=
PLC-PRF-5Mo\sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF;DXJRKSzVyPUKwMlM6ODZizszNMmLGV2FPT0WU
SW1463NUXGfpd{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHPCepFKSzVyPUKwMlQ2OjVizszNMkT2V2FPT0WU
769-PMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV;JR|UxRTJyLk[3Olkh|ryPNFGzcFRUSU6JRWK=
DMS-79NX3xd3EyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkXsTWM2OD1{MD64OFkh|ryPMYDTRW5ITVJ?
Saos-2MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn3FTWM2OD1{MD65OVU3KM7:TR?=MUnTRW5ITVJ?
CHP-126NFnWVJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MW\JR|UxRTJzLkS0OlIh|ryPM2XaZ3NCVkeHUh?=
SW837M{j5UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NG\zS4lKSzVyPUKxMlQ6OzlizszNNYqyd3F3W0GQR1XS
SHP-77M4jtTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUDJR|UxRTJzLk[xNlIh|ryPMWPTRW5ITVJ?
DBMVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlSwTWM2OD1{MT62NVQzKM7:TR?=NGX6UYVUSU6JRWK=
ES5NX;ITpJWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3n4OmlEPTB;MkGuOlg3PCEQvF2=NHHoflVUSU6JRWK=
COR-L23MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{DjWGlEPTB;MkGuPFA2OSEQvF2=NUj1cJZ5W0GQR1XS
KU-19-19MkSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2D3UWlEPTB;MkGuPFk5OiEQvF2=M{\YcHNCVkeHUh?=
T84NGPhWVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVfuUmFwUUN3ME2yNU46QDF7IN88US=>NXOxNndEW0GQR1XS
NCI-H630M{XPXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4HO[WlEPTB;MkKuOVM3OyEQvF2=M37Xd3NCVkeHUh?=
LU-165NXnheGFIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkHTTWM2OD1{Mj61OVQh|ryPNH7vTGFUSU6JRWK=
COLO-792M4XTPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MU\JR|UxRTJ{LkexNVEh|ryPMXvTRW5ITVJ?
CAL-62MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmK0TWM2OD1{Mj63OVE4KM7:TR?=M2OyN3NCVkeHUh?=
HCE-TNFPYS2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIPKO4dKSzVyPUKyMlg3ODZizszNM4HkUXNCVkeHUh?=
BB65-RCCMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTJ|LkCzOFQh|ryPM3;ifnNCVkeHUh?=
SiHaMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4T5e2lEPTB;MkOuN|k3QCEQvF2=MXvTRW5ITVJ?
NCI-H2081M1TL[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIXvcoZKSzVyPUK0MlA3PDFizszNNYf4SIZOW0GQR1XS
U251NVPhTWg5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH\H[pVKSzVyPUK0MlA3PjhizszNMX3TRW5ITVJ?
LoVoM1ezUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWrJR|UxRTJ2LkmyPFIh|ryPNUPwb5lbW0GQR1XS
GCIYMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFjWTYRKSzVyPUK1MlI5PzdizszNMYLTRW5ITVJ?
NUGC-3Ml3zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVXNOVFoUUN3ME2yOU4{OzF4IN88US=>M4PnRnNCVkeHUh?=
LNCaP-Clone-FGCMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXTmXlgxUUN3ME2yOU4{PDl6IN88US=>MlO1V2FPT0WU
PA-1MlTIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILOTWxKSzVyPUK1MlY5OzNizszNM3fyfXNCVkeHUh?=
OE33NFP2W|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MULJR|UxRTJ3Lk[4OVMh|ryPNYj5W|ZxW0GQR1XS
HT-29NUXQZWNST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYX3[pU2UUN3ME2yOU44QDd7IN88US=>MY\TRW5ITVJ?
RCM-1MoHYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{PjW2lEPTB;MkWuPVY2PiEQvF2=MWTTRW5ITVJ?
NCI-H1522NU\xZotzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MofDTWM2OD1{NT65PVEyKM7:TR?=NGroTIlUSU6JRWK=
LB373-MEL-DNHXP[pRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTJ4LkG3NFgh|ryPNGHYdItUSU6JRWK=
NCI-H1436M3O3Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWTwSW9GUUN3ME2yOk4zPzN6IN88US=>NXnsPVhPW0GQR1XS
COLO-824M2rM[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXvXc2s4UUN3ME2yOk41ODB{IN88US=>M4SxNnNCVkeHUh?=
CP50-MEL-BM1X3VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILxeolKSzVyPUK2MlU3PzVizszNNXqxb29wW0GQR1XS
EGI-1NVn0b4ZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXmwfFhkUUN3ME2yO{4zPjl6IN88US=>M4DN[HNCVkeHUh?=
LAN-6NES2UINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWjJR|UxRTJ5LkO1PVgh|ryPMmnIV2FPT0WU
GAKMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTJ5LkSyNlUh|ryPMlvlV2FPT0WU
MDA-MB-175-VIIM3XoW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTJ5LkWwOVMh|ryPMYrTRW5ITVJ?
JVM-2NWmySXIzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVTJR|UxRTJ5Lk[2NlIh|ryPMYnTRW5ITVJ?
UACC-257NWPBemR{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2O1[GlEPTB;MkeuOlg4QCEQvF2=MUPTRW5ITVJ?
SW1783NFPKPWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE[xeJBKSzVyPUK3Mlc4QDNizszNNUfQWVc1W0GQR1XS
HT-3NFnxWWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTJ6LkKxOlYh|ryPNEnxeYpUSU6JRWK=
RLNX76cGVKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUDPOnJtUUN3ME2yPE42QTFzIN88US=>MljXV2FPT0WU
TK10NUnjNJE4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlLITWM2OD1{OD62OVM2KM7:TR?=NUDobW5NW0GQR1XS
HT55M3LQcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmX2TWM2OD1{OT6wOVY2KM7:TR?=NEXOPZdUSU6JRWK=
BT-20M3TaO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWrjUoVYUUN3ME2yPU4xPTh4IN88US=>NX\iOpFnW0GQR1XS
TGBC24TKBNUXMSohYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFfEOGtKSzVyPUK5MlE5OzFizszNNEDUZlBUSU6JRWK=
HSC-2NW\CU3JwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLvdmVuUUN3ME2yPU4{ODBzIN88US=>NIjXV41USU6JRWK=
COLO-205MmrrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlvPTWM2OD1{OT6zPVQ1KM7:TR?=MWfTRW5ITVJ?
GT3TKBM1T0Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnHzTWM2OD1{OT62PFc4KM7:TR?=NYXXWXY6W0GQR1XS
T47DM4\vR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlvOTWM2OD1{OT64OVgzKM7:TR?=MXvTRW5ITVJ?
OMC-1MoLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWe0NGx6UUN3ME2zNE4yQTF7IN88US=>MnvpV2FPT0WU
PFSK-1M4DB[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFPDOYtKSzVyPUOxMlI3PTlizszNNUn6Z3VsW0GQR1XS
JEG-3Ml3XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3\PNmlEPTB;M{GuN|U3OSEQvF2=MYrTRW5ITVJ?
RDNFvp[2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\GTWM2OD1|MT61NVE2KM7:TR?=M1ntNHNCVkeHUh?=
NCI-H64MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX7JR|UxRTN{LkSxO|kh|ryPNW\vXnJsW0GQR1XS
DMS-114MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTN{LkSxPFIh|ryPNVLpOoRvW0GQR1XS
NCI-H661NFrUcYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3PFPWlEPTB;M{KuOlUxOSEQvF2=M1vJcnNCVkeHUh?=
CAL-148MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml;BTWM2OD1|Mj62OlY2KM7:TR?=NHnlSlFUSU6JRWK=
HuP-T3M{jmbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2f6OWlEPTB;M{KuPVM{QCEQvF2=MWjTRW5ITVJ?
ES4MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYWxOHp{UUN3ME2zN{4yPzB3IN88US=>M2rBNHNCVkeHUh?=
Ca9-22NXe0R484T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MknwTWM2OD1|Mz60OlAyKM7:TR?=Mo\YV2FPT0WU
LP-1M1PvSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVzDNmx1UUN3ME2zOE4xQSEQvF2=Mnm2V2FPT0WU
AU565MnTOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWTR[XdnUUN3ME2zOE42ODZ7IN88US=>MkXpV2FPT0WU
MDA-MB-453MkG3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHjyRW9KSzVyPUO1MlE1OjZizszNNWD0bWR2W0GQR1XS
SNU-C1M4jxWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3nuSWlEPTB;M{WuNVcyKM7:TR?=NVLmS|Q4W0GQR1XS
SW13NFLVSmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXvJR|UxRTN3LkSwO|Yh|ryPNFXFNllUSU6JRWK=
NCI-H2122M4C2Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mkm4TWM2OD1|NT61OVk5KM7:TR?=MUHTRW5ITVJ?
NCI-H1395NEfqNlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vTNGlEPTB;M{WuOlY6OSEQvF2=M3;SeHNCVkeHUh?=
J-RT3-T3-5M2\kb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmHwTWM2OD1|Nj6wNlk1KM7:TR?=M3rzNXNCVkeHUh?=
COR-L279M{PNPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGeybJFKSzVyPUO2MlE6QDFizszNNUTMdmZlW0GQR1XS
ATN-1Mof0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXzi[nZnUUN3ME2zOk45PTF4IN88US=>MXPTRW5ITVJ?
HCC2998NGGwRVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXfJR|UxRTN4Lki1O|Eh|ryPM3LYUHNCVkeHUh?=
UM-UC-3MnnwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvmboZKSzVyPUO2Mlg3PzVizszNNWjETmNlW0GQR1XS
DV-90M1vBVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWDJR|UxRTN4LkmwOlch|ryPMmnyV2FPT0WU
ES8MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTN4LkmzNVgh|ryPM3PuU3NCVkeHUh?=
YAPCNUPvfWRMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{fjZWlEPTB;M{[uPVY2PCEQvF2=NIHpfY9USU6JRWK=
HCC1599NX\NXJl6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTN5LkG2NVgh|ryPM4LTUXNCVkeHUh?=
UMC-11NITvfmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\TbGlEPTB;M{euNlUxOyEQvF2=M{PoSnNCVkeHUh?=
THP-1MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrieoVKSzVyPUO3MlI5PjhizszNMXTTRW5ITVJ?
OCUB-MM1WySWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MofvTWM2OD1|Nz6yPFkyKM7:TR?=NWqzZYprW0GQR1XS
NCI-H1693NWi2VHBKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGTRd3VKSzVyPUO3MlMzOzNizszNMVfTRW5ITVJ?
NCI-H345MoTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlPMTWM2OD1|Nz6zOlI1KM7:TR?=MUXTRW5ITVJ?
COLO-800M4SxNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHuxSnZKSzVyPUO3MlU3PyEQvF2=NXn6[3YxW0GQR1XS
COLO-320-HSRMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NITy[phKSzVyPUO4MlM1QTJizszNM3fGbXNCVkeHUh?=
NCI-H596M{PhW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3[1UGlEPTB;M{iuOFQ5QSEQvF2=M{H4cXNCVkeHUh?=
NCI-H187MmLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVq3TY9rUUN3ME2zPE44OzR2IN88US=>MonKV2FPT0WU
ECC4NIP5clZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGS0SYZKSzVyPUO5MlA5OTRizszNM2O4UHNCVkeHUh?=
KP-4M1THb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHETWM2OD1|OT6xNlM2KM7:TR?=M{D6e3NCVkeHUh?=
NCI-H2227MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTN7LkO5OFkh|ryPMX;TRW5ITVJ?
22RV1MkLVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1LBcmlEPTB;M{muPFM6QCEQvF2=NGDBXplUSU6JRWK=
SASMULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTRyLkC5OkDPxE1?NGDKdoRUSU6JRWK=
PANC-10-05NGnCNmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIDO[WNKSzVyPUSwMlE5OjhizszNMnrKV2FPT0WU
MDA-MB-468NYHSNVNnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2PuT2lEPTB;NECuOVM1PiEQvF2=Mn;pV2FPT0WU
RPMI-7951MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NY\I[pVbUUN3ME20NU4zODd3IN88US=>MlXuV2FPT0WU
BB49-HNCMnfNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPSPZBKUUN3ME20NU4zOTd7IN88US=>M2Xy[HNCVkeHUh?=
23132-87M3nmfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPaTWM2OD12MT6yO|MzKM7:TR?=MonXV2FPT0WU
HCC1569MlP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmHOTWM2OD12MT6yPFg2KM7:TR?=NVfUZoE2W0GQR1XS
CP66-MELM4\SOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M322Z2lEPTB;NEKuNVg5PiEQvF2=NFfXbnBUSU6JRWK=
K-562NGfkR4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUXBVlhDUUN3ME20Nk4zQDV2IN88US=>Ml\OV2FPT0WU
OCI-AML2NUHPNIMyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWfJR|UxRTR{Lki5O|Qh|ryPNH;LUWlUSU6JRWK=
SW756NF6wT41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HxUmlEPTB;NEOuNFM5QCEQvF2=MnzFV2FPT0WU
M14M2jV[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTR|LkOxPFkh|ryPNVKwZ|J1W0GQR1XS
NCI-H1623MoeyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3jOe2lEPTB;NEOuOFY1KM7:TR?=MnmxV2FPT0WU
KNS-81-FDNG\tOlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzWT|lKSzVyPUSzMlc3OiEQvF2=MXXTRW5ITVJ?
TGBC1TKBNX;yTpVqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MknkTWM2OD12Mz65NFk6KM7:TR?=NEfscpdUSU6JRWK=
RERF-LC-MSNIrqdHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTR|LkmyPFEh|ryPNHmxdoNUSU6JRWK=
PC-3MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRTR2LkSzOFch|ryPMVXTRW5ITVJ?
HuP-T4MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmfkTWM2OD12ND60OFc1KM7:TR?=M33tVXNCVkeHUh?=
NCI-H510ANVzucodtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlm2TWM2OD12ND63NFgh|ryPNWOxUoZbW0GQR1XS
LB2518-MELNYfpb5JWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH:0bpRKSzVyPUS0Mlc6OzdizszNNYPn[ZUyW0GQR1XS
TE-5MnS3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoLJTWM2OD12NT65OVgyKM7:TR?=Mnf6V2FPT0WU
EW-24MmLyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkT1TWM2OD12Nj6xO|I{KM7:TR?=Mme4V2FPT0WU
LB647-SCLCMl\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{PuUmlEPTB;NE[uNlE2PSEQvF2=M2rwbXNCVkeHUh?=
NCI-H524MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTR4LkexPFUh|ryPNWCzZ3ZuW0GQR1XS
EW-11NGrocJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWC5cIVNUUN3ME20Ok46Ozd|IN88US=>MYXTRW5ITVJ?
KALS-1NGHPNXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDOPHN4UUN3ME20O{4zODZ4IN88US=>NIDhb3lUSU6JRWK=
BT-474NVzxeWQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWnw[3RHUUN3ME20O{41OjF4IN88US=>M1m1NHNCVkeHUh?=
SK-N-ASMmjYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoryTWM2OD12Nz64PFgh|ryPNGThZoJUSU6JRWK=
HCC2157NFXOeIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M121emlEPTB;NEiuNFc3KM7:TR?=MVXTRW5ITVJ?
HCC1954NX;rOVdbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUnJR|UxRTR6LkG3NFQh|ryPNWnERoZoW0GQR1XS
FADUM1rSN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmPETWM2OD12OD6zNFMyKM7:TR?=NUK4eZA5W0GQR1XS
S-117M2TPWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M37FTWlEPTB;NEiuN|gyPSEQvF2=MlLrV2FPT0WU
LS-1034NInzSlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUj3R4c2UUN3ME20PE44ODZ5IN88US=>NV;UXmVYW0GQR1XS
CAMA-1MlTWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTR7LkW1OFMh|ryPMoftV2FPT0WU
LU-134-ANUnZVYNDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2LaNWlEPTB;NEmuPFA5PSEQvF2=MXTTRW5ITVJ?
NCI-H1838NF7KenJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4P4UWlEPTB;NEmuPFA5PyEQvF2=NUHDeHlMW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo In a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, AP24534 (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Peptide substrate phosphorylation assays with GST-Abl kinase domains The effect of AP24534 (0-320 nM) on GST-Abl kinase activity is assessed by using a synthetic peptide substrate (Abltide: EAIYAAPFAKKK). Assays are carried out at 30 °C for 15 min in 25 μL reaction mixture: 8 mM MOPS (pH 7), 0.2 mM EDTA, 50 μM Abltide, 30 mM MgCl2, 10 mM β-glycerol phosphate, 1 mM EGTA, 0.002% Brij-35, 0.4 mM DTT, 0.2 mg/mL BSA, 0.4 mM sodium orthovanadate, 10 nM WT or mutant GST-Abl kinase, and 100 µM ATP/γ-32[P]ATP (5000 cpm/pmol). Reactions are terminated by transferring a portion of the reaction mixture onto a p81 phosphocellulose filter and immersing in 0.75% phosphoric acid. Filters are washed 3 times in 0.75% phosphoric acid, rinsed in acetone, and air dried; phosphate incorporation is determined by scintillation counting. All results are corrected for background binding to the filters, as determined by omitting peptide substrate from the kinase reaction. Time course experiments to establish the linear range of enzymatic activity precedes kinase assays.

Cell Assay: [2]

Cell lines Ba/F3 cells expressing Bcr-Abl or a range of single mutations in the kinase domain of Bcr-Abl
Concentrations 0-625 nM
Incubation Time 72 hours
Method Ba/F3 cell lines are distributed in 96-well plates (4 × 103 cells/well) and incubated with AP24534 for 72 hours. Proliferation is measured using a methanethiosulfonate (MTS)-based viability assay (CellTiter96 Aqueous One Solution). All values are normalized to the control wells with no drug. IC50 values are reported as the mean of three independent experiments performed in quadruplicat

Animal Study: [1]

Animal Models Mouse xenograft models of Ba/F3 cells expressing Bcr-Abl or Bcr-AblT315I
Formulation Dissolved in 25 mM citrate buffer, pH 2.75
Dosages 2.5 mg/kg and 5 mg/kg for Ba/F3 Bcr-Abl; 2.5 mg/kg–50 mg/kg for Ba/F3 Bcr-AblT315I
Administration Oral gavage once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] O'Hare T, et al. Cancer Cell, 2009, 16(5), 401-412.

[2] Huang WS, et al. J Med Chem, 2010, 53(12), 4701-4719.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-05-29)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02776605 Not yet recruiting ALL PETHEMA Foundation June 2016 Phase 2
NCT01888562 Withdrawn Endometrial Neoplasms Washington University School of Medicine January 2016 --
NCT02627677 Recruiting Chronic Phase Chronic Myeloid Leukemia Ariad Pharmaceuticals December 2015 Phase 3
NCT02398825 Not yet recruiting Chronic Myeloid Leukemia|Chronic Phase|Adults Gruppo Italiano Malattie EMatologiche dellAdulto December 2015 Phase 2
NCT02779283 Recruiting Untreated Adult Acute Myeloid Leukemia OHSU Knight Cancer Institute|National Cancer Institute (NCI) December 2015 Phase 1

view more

Chemical Information

Download Ponatinib (AP24534) SDF
Molecular Weight (MW) 532.56
Formula

C29H27F3N6O

CAS No. 943319-70-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 30 mg/mL (56.33 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Customer Product Validation (2)


Click to enlarge
Rating
Source Cancer Cell 2012 22(5), 656-667 . Ponatinib (AP24534) purchased from Selleck
Method Western blot
Cell Lines RCH-ACV cells
Concentrations 50 nM
Incubation Time 1-24 h
Results Treatment of these cells with a CSK inhibitor (BMS-599626) or a BTK inhibitor (PCI-32765) did not recapitulate the dasatinib/ponatinib phenotype.

Click to enlarge
Rating
Source Genome Biol, 2014, 15(8): 428 . Ponatinib (AP24534) purchased from Selleck
Method Cell Proliferation Assay
Cell Lines KatoIII cells
Concentrations 0-0.5 nM
Incubation Time
Results Each of the inhibitors demonstrated a statistically significant lower IC50 in FGFR2-amplified KatoIII cells compared to non-FGFR2-amplified AGS cells at all concentrations tested.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcr-Abl Products

  • PX-478 2HCl

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. Phase 1.

  • Defactinib (VS-6063, PF-04554878)

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • Imatinib Mesylate (STI571)

    Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

  • Nilotinib (AMN-107)

    Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenitor cells.

    Features:A selective inhibitor of native and mutant Bcr-Abl.

  • Bafetinib (INNO-406)

    Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 nM in cell-free assays, does not inhibit the phosphorylation of the T315I mutant and is less potent to PDGFR and c-Kit. Phase 2.

    Features:Dual Bcr-Abl/Lyn inhibitor.

  • Degrasyn (WP1130)

    Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).

    Features:WP1130 has an advantage over imatinib mesylate in that its activity is not inhibited by a variety of Abl kinase mutations, including T315I.

  • DCC-2036 (Rebastinib)

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Features:A conformational control inhibitor of Abl1 and T315I Abl1.

  • GZD824 Dimesylate

    GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

  • GNF-2

    GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.

Recently Viewed Items

Tags: buy Ponatinib (AP24534) | Ponatinib (AP24534) ic50 | Ponatinib (AP24534) price | Ponatinib (AP24534) cost | Ponatinib (AP24534) solubility dmso | Ponatinib (AP24534) purchase | Ponatinib (AP24534) manufacturer | Ponatinib (AP24534) research buy | Ponatinib (AP24534) order | Ponatinib (AP24534) mouse | Ponatinib (AP24534) chemical structure | Ponatinib (AP24534) mw | Ponatinib (AP24534) molecular weight | Ponatinib (AP24534) datasheet | Ponatinib (AP24534) supplier | Ponatinib (AP24534) in vitro | Ponatinib (AP24534) cell line | Ponatinib (AP24534) concentration | Ponatinib (AP24534) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us